| A New Membrane Obturator Prothesis Concept for Soft Palate Defects (NCT04009811) | University Hospital, Bordeaux | 2020-07-17 |
| GDF15 Based TPF Induction Chemotherapy for OSCC Patients (NCT02285530) | Shanghai Jiao Tong University School of Medicine | 2019-12-01 |
| Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage (NCT02290145) | Shanghai Jiao Tong University School of Medicine | 2016-12-01 |
| A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients (NCT02285543) | Shanghai Jiao Tong University School of Medicine | 2016-12-01 |
| GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer (NCT01553851) | Washington University School of Medicine | 2013-02-01 |
| Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity (NCT02604121) | University Hospital, Toulouse | 2013-02-01 |
| The Feasibility Study of Dual-Section Nasogastric Tube (NCT01649349) | Changhua Christian Hospital | 2012-05-01 |
| Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer (NCT01216020) | Azienda USL 4 Prato | 2010-10-01 |
| Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma (NCT01195922) | National Institute of Dental and Craniofacial Research (NIDCR) | 2010-08-01 |
| Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers (NCT01104714) | Centre Hospitalier Universitaire de Nīmes | 2010-04-01 |
| Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity (NCT00953849) | VA Office of Research and Development | 2009-11-01 |
| F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients (NCT00721799) | University of Iowa | 2008-03-01 |
| Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer (NCT00272181) | Sesen Bio, Inc. | 2006-01-01 |
| Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer (NCT00412776) | Sesen Bio, Inc. | 2005-12-01 |
| Oral Cancer Adjuvant Therapy (OCAT) Trial (NCT00193843) | Tata Memorial Hospital | 2005-06-01 |
| Biomarkers for Oral Cancer (NCT00341497) | National Cancer Institute (NCI) | 1996-08-28 |